Averill Master Fund, Ltd.
CIK 0001939329 Name as filed on the most recent filing
Filed as Averill Master Fund, Ltd. (9)
49 transaction lines · from 9 filings · filed 2024-11-21 to 2026-02-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-06 |
Veradermics, Inc MANE |
P, Open-market purchase | 19,338 acquired | 36.55 | 706,803.90 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-06 |
Veradermics, Inc MANE |
P, Open-market purchase | 11,183 acquired | 35.97 | 402,252.51 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 38,771 acquired | 37.63 | 1,458,952.73 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 19,199 acquired | 36.93 | 709,019.07 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 17,835 acquired | 38.67 | 689,679.45 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 16,563 acquired | 39.80 | 659,207.40 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 3,832 acquired | 36.07 | 138,220.24 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 53,344 acquired | 37.11 | 1,979,595.84 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 25,908 acquired | 38.09 | 986,835.72 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 18,489 acquired | 38.90 | 719,222.10 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 14,659 acquired | 36.27 | 531,681.93 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 10,676 acquired | 34.74 | 370,884.24 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 10,004 acquired | 34.25 | 342,637.00 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 9,168 acquired | 37.11 | 340,224.48 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 4,453 acquired | 38.09 | 169,614.77 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 3,178 acquired | 38.90 | 123,624.20 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 2,519 acquired | 36.27 | 91,364.13 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 1,835 acquired | 34.74 | 63,747.90 | Form 4, filing 0000899140-26-000140 | |
| 2026-02-04 |
Veradermics, Inc MANE |
P, Open-market purchase | 1,720 acquired | 34.25 | 58,910.00 | Form 4, filing 0000899140-26-000140 | |
| 2025-12-29 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 65,800 acquired | 13.44 | 884,352.00 | Form 4, filing 0000899140-25-001479 | |
| 2025-12-29 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 11,587 acquired | 13.44 | 155,729.28 | Form 4, filing 0000899140-25-001479 | |
| 2025-12-26 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 14,320 acquired | 13.10 | 187,592.00 | Form 4, filing 0000899140-25-001479 | |
| 2025-12-26 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 2,516 acquired | 13.10 | 32,959.60 | Form 4, filing 0000899140-25-001479 | |
| 2025-12-23 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 42,600 acquired | 12.85 | 547,410.00 | Form 4, filing 0000899140-25-001479 | |
| 2025-12-23 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 7,400 acquired | 12.85 | 95,090.00 | Form 4, filing 0000899140-25-001479 | |
| 2025-12-22 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 16,650 acquired | 12.08 | 201,132.00 | Form 4, filing 0000899140-25-001459 | |
| 2025-12-22 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 2,892 acquired | 12.08 | 34,935.36 | Form 4, filing 0000899140-25-001459 | |
| 2025-12-19 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 13,950 acquired | 11.48 | 160,146.00 | Form 4, filing 0000899140-25-001459 | |
| 2025-12-19 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 2,434 acquired | 11.48 | 27,942.32 | Form 4, filing 0000899140-25-001459 | |
| 2025-12-18 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 8,700 acquired | 11.24 | 97,788.00 | Form 4, filing 0000899140-25-001459 | |
| 2025-12-18 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 1,515 acquired | 11.24 | 17,028.60 | Form 4, filing 0000899140-25-001459 | |
| 2025-11-07 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 751,111 acquired | 13.50 | 10,139,998.50 | Form 4, filing 0000899140-25-001256 | |
| 2025-11-07 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 730,370 acquired | 13.50 | 9,859,995.00 | Form 4, filing 0000899140-25-001256 | |
| 2025-03-31 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 9,503 acquired | 12.63 | 120,022.89 | Form 4, filing 0000899140-25-000486 | |
| 2025-03-31 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 5,057 acquired | 13.22 | 66,853.54 | Form 4, filing 0000899140-25-000486 | |
| 2025-03-31 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 1,267 acquired | 12.63 | 16,002.21 | Form 4, filing 0000899140-25-000486 | |
| 2025-03-31 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 670 acquired | 13.22 | 8,857.40 | Form 4, filing 0000899140-25-000486 | |
| 2025-03-26 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 793,800 acquired | 13.00 | 10,319,400.00 | Form 4, filing 0000899140-25-000479 | |
| 2025-03-26 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 106,200 acquired | 13.00 | 1,380,600.00 | Form 4, filing 0000899140-25-000479 | |
| 2024-12-24 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 17,730 acquired | 11.25 | 199,462.50 | Form 4, filing 0000899140-24-001385 | |
| 2024-12-24 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 2,288 acquired | 11.25 | 25,740.00 | Form 4, filing 0000899140-24-001385 | |
| 2024-12-23 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 24,360 acquired | 10.98 | 267,472.80 | Form 4, filing 0000899140-24-001385 | |
| 2024-12-23 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 3,142 acquired | 10.98 | 34,499.16 | Form 4, filing 0000899140-24-001385 | |
| 2024-12-03 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 37,190 acquired | 9.60 | 357,024.00 | Form 4, filing 0000899140-24-001318 | |
| 2024-12-03 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 4,810 acquired | 9.60 | 46,176.00 | Form 4, filing 0000899140-24-001318 | |
| 2024-11-20 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 24,360 acquired | 10.22 | 248,959.20 | Form 4, filing 0000899140-24-001299 | |
| 2024-11-20 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 3,076 acquired | 10.22 | 31,436.72 | Form 4, filing 0000899140-24-001299 | |
| 2024-11-19 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 12,430 acquired | 9.73 | 120,943.90 | Form 4, filing 0000899140-24-001299 | |
| 2024-11-19 |
Benitec Biopharma Inc. BNTC |
P, Open-market purchase | 1,570 acquired | 9.73 | 15,276.10 | Form 4, filing 0000899140-24-001299 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Averill Master Fund, Ltd., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001939329
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6